David Tolley > Latham & Watkins LLP > Washington DC, United States > Lawyer Profile
Latham & Watkins LLP Offices

555 ELEVENTH STREET, NW, SUITE 1000
WASHINGTON DC 20004-1304
DISTRICT OF COLUMBIA
United States
- Firm Profile
- Go to...
David Tolley

Position
David Tolley, Chair of the Boston Litigation & Trial Department, represents healthcare and life sciences companies in high-stakes government investigations and litigation.
David represents clients in a variety of investigative, litigation, regulatory, and compliance matters. He represents a full spectrum of industry clients, including:
- Hospital systems
- Insurers
- Medical device and pharmaceutical companies
- Pharmacy benefit managers
- Pharmaceutical distributors
He helps clients navigate their highest-stakes issues involving the False Claims Act, the Anti-Kickback Statute, and their state analogs. He draws on extensive experience with government regulators and prosecutors including those from the:
- Department of Justice
- Department of Health and Human Services (HHS) – Office of Inspector General
- Centers for Medicare & Medicaid Services
- HHS – Office for Civil Rights
- State Attorneys General
David helps clients frame complex issues and advocates on their behalf based on a sophisticated understanding of both the law and the industry, his background in medical ethics and health policy, and his ability to deescalate and navigate strategically through high-pressure situations.
Industry Leadership and Pro Bono
David serves as an advisory board member of The Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School. He has served as a Chapter President for the Healthcare Financial Management Association and is a member of the American Health Lawyers Association. He works regularly with the Center for Health Law Policy Innovation at Harvard Law School, pursuing pro bono litigation against state Medicaid agencies on behalf of people with Hepatitis C denied access to curative therapies.
Lawyer Rankings
United States > Healthcare > Health insurers
The interdisciplinary team at Latham & Watkins LLP flexes its muscles across regulatory, transactional, and contentious healthcare law matters, notably representing some of the country’s most prominent health insurance carriers in high-stakes litigation. The group is led by a DC trio of John Manthei
, Ben Haas, and Jason Caron, and Chicago-based partner Terra Reynolds. The department has experience handling M&A and large-scale transactions in the healthcare space, managing lawsuits regarding Medicare Advantage regulation, and supporting clients facing government agency investigations and disputes, in addition to a range of other matters. Former General Counsel of the United States Department of Health and Human Services Daniel Meron contributes deep regulatory and investigatory expertise to the practice, and David Tolley assists insurers facing government investigations as well as representing them in court.
United States > Healthcare > Service providers
Primarily based in Washington DC, the practice at Latham & Watkins LLP stands out for its strength in healthcare private equity transactions, healthcare system bankruptcies, and 340B program issues. John Manthei
, Ben Haas, Jason Caron, and Terra Reynolds jointly lead the practice. Caron often advises health systems and private investors on affiliations, public mergers, and joint ventures, and California’s Heather Deixler is well-known for her deep knowledge of genetic and de-identified data and its use in compliance with HIPAA and HITECH. In Chicago, Reynolds is noted for handling white-collar crime issues within the healthcare sector. Joseph Hudzik is a key contact for healthcare fraud and abuse compliance work. David Tolley works out of the Boston office, and regularly represents insurers, hospital systems, and pharmacy benefit managers in FCA and AKS investigations and disputes.
Lawyer Rankings
Top Tier Firm Rankings
- Insurance > Advice to policyholders
- Dispute resolution > Appellate: courts of appeals / Appellate: supreme courts (states and federal)
- Finance > Capital markets: debt offerings
- Finance > Capital markets: equity offerings
- Finance > Capital markets: global offerings
- Finance > Capital markets: high-yield debt offerings
- Antitrust > Cartel
- International trade and national security > CFIUS
- Antitrust > Civil litigation/class actions: defense
- Finance > Commercial lending
- Finance > Commercial lending: Advice to bank lenders
- Intellectual property > Copyright
- Media, technology and telecoms > Cyber law (including data privacy and data protection)
- Labor and employment > Employee benefits, executive compensation and retirement plans: transactional
- Energy > Energy transactions: electric power
- Energy > Energy transactions: oil and gas
- Environment > Environment: litigation
- Environment > Environment: regulatory
- Environment > Environment: transactional
- Finance > Fintech
- Dispute resolution > General commercial disputes
- Real estate > Land use/zoning
- Intellectual property > Patents: licensing
- Healthcare > Life sciences
- Dispute resolution > M&A litigation: defense
- M&A/corporate and commercial > M&A: large deals ($1bn+)
- Media, technology and telecoms > Media and entertainment: litigation
- Media, technology and telecoms > Media and entertainment: transactional
- Antitrust > Merger control
- International trade and national security > National Security
- Intellectual property > Patents: licensing
- Intellectual property > Patents: licensing
- Intellectual property > Patents: litigation (full coverage)
- Intellectual property > Patents: litigation (International Trade Commission)
- M&A/corporate and commercial > Private equity buyouts: large deals ($500m+)
- Dispute resolution > Product liability, mass tort and class action - defense: consumer products (including tobacco)
- Dispute resolution > Product liability, mass tort and class action - defense: toxic tort
- Finance > Project finance
- Real estate > Real estate
- Real estate > Real estate investment trusts (REITs)
- Energy > Renewable/alternative power
- Finance > Restructuring (including bankruptcy): corporate
- Dispute resolution > Securities litigation: defense
- M&A/corporate and commercial > Shareholder activism
- Industry focus > Sport
- Finance > Structured finance: derivatives and structured products
- Finance > Structured finance: securitization
- Media, technology and telecoms > Technology transactions
- Media, technology and telecoms > Telecoms and broadcast: regulatory
- Media, technology and telecoms > Telecoms and broadcast: transactions
- Intellectual property > Trade secrets (litigation and non-contentious matters)
- Tax > US taxes: contentious
- Tax > US taxes: non-contentious
- M&A/corporate and commercial > Venture capital and emerging companies
Firm Rankings
- M&A/corporate and commercial > Corporate governance
- International trade and national security > Customs, export controls and economic sanctions
- Industry focus > Education
- Energy > Energy regulation: electric power
- Energy > Energy regulation: oil and gas
- Government > Government contracts
- Insurance > Insurance: non-contentious
- Dispute resolution > International litigation
- Dispute resolution > Leading trial lawyers
- Investment fund formation and management > Private equity funds (including venture capital)
- Dispute resolution > Financial services litigation
- Healthcare > Health insurers
- Media, technology and telecoms > Outsourcing
- Healthcare > Service providers
- Dispute resolution > International arbitration
- Dispute resolution > Leading trial lawyers
- Intellectual property > Trademarks: litigation
- Dispute resolution > Leading trial lawyers
- Finance > Financial services regulation
- Finance > Commercial lending > Advice to direct lenders/private credit
- Dispute resolution > Corporate investigations and white-collar criminal defense